Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Neoplasm
100%
Malignant Neoplasm
92%
Overall Survival
82%
Recurrent Disease
76%
Hepatectomy
72%
Tumor
57%
Colorectal Liver Metastasis
55%
Esophagectomy
54%
Liver Tumor
52%
Radiofrequency Ablation
50%
Abdominal Cancer
50%
Biological Marker
50%
Diseases
48%
Neoadjuvant Chemotherapy
44%
Breast Cancer
44%
Gastrectomy
41%
Cholangiocarcinoma
39%
Esophagojejunostomy
37%
Cancer
36%
Surgeon
36%
Chemoradiotherapy
33%
Indocyanine Green
33%
Neoadjuvant Therapy
33%
Pancreas Adenocarcinoma
33%
Adenocarcinoma
33%
Metastatic Carcinoma
31%
Joint Committee
29%
Sleeve Gastrectomy
29%
Surgical Oncology
28%
Endoscopic Ultrasound
27%
Gamma Urogastrone
25%
Epidermal Growth Factor Receptor 2
25%
Fistula
25%
Morbidity
24%
Cross-Sectional Imaging
24%
Liver Metastasis
24%
Cell Cycle
24%
Laparoscopic Surgery
23%
Disease Free Survival
23%
Estrogen Receptor
21%
Transcriptomics
21%
Cyclin-Dependent Kinase
20%
Gastroesophageal Junction
20%
Cancer Staging
19%
Tumor Ablation
19%
Multivariate Analysis
19%
Cell Proliferation
17%
Recurrence Risk
17%
Chemotherapy
17%
Systematic Review
16%
Keyphrases
Tumor
70%
Overall Survival
61%
Breast Cancer
55%
Colorectal Cancer Liver Metastasis (CRCLM)
55%
Resection
44%
Neoadjuvant Chemotherapy
44%
Gastrojejunostomy
37%
Ablation
37%
Local Recurrence
35%
Neoadjuvant
33%
Neoadjuvant Chemoradiotherapy (nCRT)
33%
Pancreatic Ductal Adenocarcinoma
33%
Laparoscopic Radiofrequency Ablation
33%
Thermosphere
33%
Total Gastrectomy
33%
Minimally Invasive Esophagectomy
33%
Prognostic Biomarker
33%
Neoadjuvant Therapy
33%
Primary Liver Cancer
33%
Sleeve Gastrectomy
33%
Indocyanine Green Fluorescence
33%
Liver Resection
32%
Surgical Oncology
29%
Indocyanine Green
29%
Cross-sectional Imaging
28%
Patient Survival
27%
Surgeons
27%
Risk Factors
26%
Metastasis
25%
Gene Set
24%
Liver
24%
Disease-free Survival
23%
Human Epidermal Growth Factor Receptor 2 (HER2)
23%
Human Epidermal Growth Factor Receptor 2-negative
22%
Estrogen Receptor-positive
22%
High-score
22%
Neuroendocrine Tumor Liver Metastases
22%
Endoscopic Ultrasound
22%
Fistula
22%
Tumor Ablation
21%
Cell Proliferation
21%
Single Center
20%
Hepatectomy
20%
Esophagectomy
20%
Liver Tumor
20%
Radiofrequency Ablation
20%
Robotics
20%
Laparoscopic Liver Resection
19%
Hepatocellular Carcinoma
19%
Surgical Resection
19%